Niche Demonstration Only

The most practical constraint is that biological computing remains difficult to scale, standardize, and maintain outside controlled laboratory settings. In this scenario, the tool is viewed as an interesting proof of concept but not a near-term commercial competitor to conventional AI video systems.

Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.